Roche says 'no thanks' to megadeals, but don't count out smaller M&A

After two recent, huge tie-ups between Takeda and Shire and Bristol-Myers Squibb and Celgene, megamergers seem to be a biopharma trend. But Roche isn't interested, its chairman said.